Monode Marking Products, Inc. v. Columbia Marking Tools, Inc.

CourtDistrict Court, N.D. Ohio
DecidedSeptember 27, 2019
Docket1:18-cv-00016
StatusUnknown

This text of Monode Marking Products, Inc. v. Columbia Marking Tools, Inc. (Monode Marking Products, Inc. v. Columbia Marking Tools, Inc.) is published on Counsel Stack Legal Research, covering District Court, N.D. Ohio primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Monode Marking Products, Inc. v. Columbia Marking Tools, Inc., (N.D. Ohio 2019).

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE NORTHERN DISTRICT OF OHIO EASTERN DIVISION MONODE MARKING ) CASE NO.: 1:18 CV 16 PRODUCTS, INC., ) ) Plaintiff, ) JUDGE DONALD C. NUGENT ) . Vv. ) ) COLUMBIA MARKING TOOLS, INC., ) MEMORANDUM OPINION ) AND ORDER Defendant. )

This matter is before the Court following a Claim Construction hearing held on July 30, 2019, prior to which the Parties filed their Opening Briefs on Claim Construction (Docket #s 23 and 24); Response Briefs (Docket #s 25 and 27); and, a Joint Letter Regarding Claim Construction and Prehearing Statement (Docket #29). In addition, following the July 30, 2019 Hearing, the Parties submitted Post-Hearing Findings of Fact and Conclusions of Law (Docket #s 33, 34 and 35). Accordingly, the Claim Construction issues in the instant matter are now ripe for determination. I. Background. On January 3, 2018, Plaintiff, Monode Marking Products, Inc. (“Monode”), filed this lawsuit against Defendant, Columbia Marking Tools, Inc. (“Columbia”), alleging infringement of U.S. Patent No. 6,974,082 (“the ’082 Patent”). As stated in the Complaint, “the ’082 Patent is generally directed to unique integrated marking systems, including integrated marking and

reading stations that control reading or marking of encoded information onto an article.” Monode alleges that Columbia’s I-Mark Software, including but not limited to the I-Mark II- Read System and compatible marking tools and accessories, infringes the ’082 Patent. Columbia filed a Counterclaim against Monode, seeking declaratory judgment from the Court establishing that Columbia’s products do not infringe on the °082 Patent and that the ’082 Patent is invalid. As discussed at length during the Claim Construction Hearing, Columbia argues that the ’082 Patent is invalid due to indefiniteness — specifically, that the ‘082 Patent fails to comply with the statutory requirements of clearly associating structure (i.e., an algorithm) to the claimed software functions, as required under 35 U.S.C. § 112(2) for “means-plus-function” claiming. II. Standard of Review. An infringement analysis entails two steps. The first step is determining the meaning and scope of the patent claims asserted to be infringed. The second step is comparing the properly construed claims to the product accused of infringing. See Markman v. Westview Instruments, Ine., 52 F.3d 967, 976 (Fed. Cir. 1995) (en banc), aff'd, 517 U.S. 370 (1996). It is the first step, commonly known as claim construction or interpretation, that is at issue at this juncture. Construction of patent claims is a question of law for the Court. Jd. at 970-71. Indefiniteness. “Indefiniteness is a matter of claim construction, and the same principles that govern claim construction are applicable to determining whether allegedly indefinite claim language is subject to construction.” Praxair, Inc. v. ATMI, Inc., 543 F.3d 1306, 1319 (citing Datamize, LLC v. Plumtree Software, Inc., 417 F.3d 1342, 1348 (Fed. Cir. 2005)). “[A] patent is invalid for indefiniteness if its claims, read in light of the specification delineating the patent, and the

prosecution history, fail to inform, with reasonable certainty, those skilled in the art about the scope of the invention.” Nautilus, Inc. v. Biosig Instruments, Inc., 572 U.S. 898, 901 (2014). Under this standard, a patent must be “precise enough to afford clear notice of what is claimed,” Biosig Instruments, Inc. v. Nautilus, Inc., 783 F.3d 1374, 1378 (Fed. Cir. 2015), while recognizing “that absolute precision is unattainable,” Nautilus, 572 U.S. at 910. A patent’s claims carry a presumption of validity and, “‘consistent with that principal, a [fact finder is] instructed to evaluate . . . whether an invalidity defense has been proved by clear and convincing evidence.’” Biosig, 783 at 1377 (citation omitted). “[The] burden of proving indefiniteness remains on the party challenging validity.” Dow Chem. Co. v. NOVA Chems. Corp. (Can.), 809 F.3d 1223, 1227 (Fed. Cir. 2015). Means-Plus-Function Claiming and Indefiniteness. Under 35 U.S.C. § 112, “[a]n element in a claim for a combination may be expressed as a means or step for performing a specified function without the recital of structure, material or acts in support thereof, and such a claim shall be construed to cover the corresponding structure, material or acts described in the specification and equivalents thereof.” 35 U.S.C. § 112. This form of claiming, known as “means-plus-function,” “allows a patentee to express a claim limitation by reciting a function to be performed rather than by reciting structure for performing that function, while placing specific constraints on how such a limitation is to be construed, namely, by restricting the scope of coverage to only the structure, materials, or acts described in the specification as corresponding to the claimed function and equivalents thereof.” Williamson v. Citrix Online, LLC, 792 F.3d 1339, 1347-48 (Fed. Cir. 2015) (citing Northrop Grumman Corp. v. Intel Corp., 325 F.3d 1346, 1350 (Fed. Cir. 2003)).

“Structure disclosed in the specification qualifies as ‘corresponding structure’ if the intrinsic evidence clearly links or associates that structure to the function recited in the claim. Id. (citing B. Braun Med., Inc. v. Abbott Labs., 124 F.3d 1419, 1424 (Fed. Cir. 1997)). “Even if the specification discloses corresponding structure, the disclosure must be of ‘adequate’ corresponding structure to achieve the claimed function.” Jd. at 1311-12 (citing In re Donaldson Co., 16 F.3d 1189, 1195 (Fed. Cir. 1994) (en banc)). “Under 35 U.S.C. § 112, paras. 2 and 6, therefore, if a person of ordinary skill in the art would be unable to recognize the structure in the specification and associate it with the corresponding function in the claim, a means-plus-function clause is indefinite.” Jd. at 1312 (citing AllVoice Computing PLC v. Nuance Commc'ns, Inc., 504 F.3d 1236, 1241 (Fed. Cir. 2007)).” Williamson, 792 F.3d at 1352. The Parties agree that the disputed claim terms of the 082 patent are expressed as “means-plus-function” claims. Once a claim element has been identified as being in means-plus- function form, its construction is a two-step process. Williamson, 792 F.3d at 1351. First, the Court must identify the claimed function, and second it must “determine what structure, if any, disclosed in the specification corresponds to the claimed function.” Jd.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Praxair, Inc. v. Atmi, Inc.
543 F.3d 1306 (Federal Circuit, 2008)
Allvoice Computing PLC v. Nuance Communications, Inc.
504 F.3d 1236 (Federal Circuit, 2007)
Datamize, L.L.C. v. Plumtree Software, Inc.
417 F.3d 1342 (Federal Circuit, 2005)
Ergo Licensing, LLC v. Carefusion 303, Inc.
673 F.3d 1361 (Federal Circuit, 2012)
In Re Donaldson Company, Inc
16 F.3d 1189 (Federal Circuit, 1994)
Nautilus, Inc. v. Biosig Instruments, Inc.
134 S. Ct. 2120 (Supreme Court, 2014)
Biosig Instruments, Inc. v. Nautilus, Inc.
783 F.3d 1374 (Federal Circuit, 2015)
Richard Williamson v. Citrix Online, LLC
792 F.3d 1339 (Federal Circuit, 2015)
Bethany Williams v. National Union Fire Ins.
792 F.3d 1136 (Ninth Circuit, 2015)
The Dow Chemical Company v. Nova Chemicals Corporation
809 F.3d 1223 (Federal Circuit, 2015)
Northrop Grumman Corp. v. Intel Corp.
325 F.3d 1346 (Federal Circuit, 2003)

Cite This Page — Counsel Stack

Bluebook (online)
Monode Marking Products, Inc. v. Columbia Marking Tools, Inc., Counsel Stack Legal Research, https://law.counselstack.com/opinion/monode-marking-products-inc-v-columbia-marking-tools-inc-ohnd-2019.